These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31318517)

  • 1. Ensuring appropriate access to pulmonary arterial hypertension therapy.
    Highland KB; Hughes KE; Williams KJ; Kyei-Baffour B; Ferguson S
    Am J Manag Care; 2019 Jun; 25(7 Suppl):S119-S127. PubMed ID: 31318517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and medical therapy of pulmonary arterial hypertension.
    Galiè N; Channick RN; Frantz RP; Grünig E; Jing ZC; Moiseeva O; Preston IR; Pulido T; Safdar Z; Tamura Y; McLaughlin VV
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in targeted therapy for pulmonary arterial hypertension in children.
    Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
    Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies.
    Rucker JA; Beinfeld MT; Enright DE; Germack HD; Panjabi S; Chakinala MM; Chambers JD
    J Manag Care Spec Pharm; 2024 Jun; 30(6):541-548. PubMed ID: 38824632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
    Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
    Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary arterial hypertension from the risk assessment to combined treatment].
    Santos-Martínez LE; Moreno-Ruiz LA; Cabrera-Ramírez C; Mendoza-Pérez BC; Galván-Oseguera H; Magaña-Serrano JA; Lupercio-Mora K; Saturno-Chiu G
    Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):314-323. PubMed ID: 32568487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of pathogenetic therapy of pulmonary arterial hypertension].
    Chazova IE; Yarovoy SY; Danilov NM
    Ter Arkh; 2019 Dec; 91(12):4-9. PubMed ID: 32598582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Pulmonary Arterial Hypertension in the Pediatric Patient.
    Ezekian JE; Hill KD
    Curr Cardiol Rep; 2019 Nov; 21(12):162. PubMed ID: 31781972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
    Luo Q; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Zhang Y; Xiong C; Liu Z
    BMC Pulm Med; 2019 Dec; 19(1):257. PubMed ID: 31856792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary hypertension: definition, classification and treatments].
    Jutant EM; Humbert M
    Biol Aujourdhui; 2016; 210(2):53-64. PubMed ID: 27687597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pulmonary arterial hypertension.
    McLaughlin VV; Shah SJ; Souza R; Humbert M
    J Am Coll Cardiol; 2015 May; 65(18):1976-97. PubMed ID: 25953750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.
    Zheng W; Wang Z; Jiang X; Zhao Q; Shen J
    J Med Chem; 2020 Dec; 63(24):15153-15186. PubMed ID: 33314936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Treatment of Pulmonary Arterial Hypertension.
    Sahay S; Humbert M; Sitbon O
    Semin Respir Crit Care Med; 2017 Oct; 38(5):686-700. PubMed ID: 29032569
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.
    Arora TK; Arora AK; Sachdeva MK; Rajput SK; Sharma AK
    J Cell Physiol; 2018 May; 233(5):3794-3804. PubMed ID: 28926093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of pulmonary arterial hypertension].
    Sitbon O; Savale L; Jaïs X; Montani D; Humbert M; Simonneau G
    Presse Med; 2014 Sep; 43(9):981-93. PubMed ID: 25153783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.